They are highly enriched in Asian, nonsmokers, females’ adenocarcinomas, they are associated with poor outcomes, and their frequency has been estimated between 4 and 10% of all documented EGFR alterations in NSCLC [44]. The gene discussed is EGFR; the disease is adenocarcinoma.